We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$3.11B
AUM Growth
+$140M
Cap. Flow
-$14.3M
Cap. Flow %
-0.46%
Top 10 Hldgs %
31.89%
Holding
3,618
New
197
Increased
1,211
Reduced
1,200
Closed
258

Sector Composition

Rank Sector Weight
1 Technology 15.43%
2 Healthcare 8.51%
3 Financials 6.64%
4 Consumer Discretionary 4.61%
5 Communication Services 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVT icon
1176
Avnet
AVT
$7.92B
$80.1K ﹤0.01%
1,587
+795
+100% +$35K
BAC.PRL icon
1177
Bank of America Series L
BAC.PRL
$4.01B
$79.7K ﹤0.01%
68
+25
+58% +$29.3K
IQ icon
1178
iQIYI
IQ
$1.34B
$79.4K ﹤0.01%
14,871
+6,615
+80% +$37.2K
CINF icon
1179
Cincinnati Financial
CINF
$26.8B
$79.4K ﹤0.01%
815
-396
-33% -$40.9K
WCC
1180
WESCO International
WCC
$18B
$79.3K ﹤0.01%
443
-200
-31% -$29.2K
LEA icon
1181
Lear
LEA
$8.08B
$79.3K ﹤0.01%
552
-105
-16% -$13.9K
LQDH icon
1182
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$540M
$79.2K ﹤0.01%
852
-105
-11% -$9.6K
CX icon
1183
Cemex
CX
$16.4B
$79K ﹤0.01%
11,159
+581
+5% +$3.7K
IBDU icon
1184
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.06B
$78.6K ﹤0.01%
3,500
CLGN icon
1185
CollPlant Biotechnologies
CLGN
$6.05M
$78.5K ﹤0.01%
9,614
ITCI
1186
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$78K ﹤0.01%
1,232
IDA icon
1187
Idacorp
IDA
$8.09B
$77.8K ﹤0.01%
758
-218
-22% -$23.4K
TRMB icon
1188
Trimble
TRMB
$13.8B
$77.3K ﹤0.01%
1,460
+598
+69% +$29.2K
DEW icon
1189
WisdomTree Global High Dividend Fund
DEW
$155M
$77.2K ﹤0.01%
1,659
+7
+0.4% +$327
BANF icon
1190
BancFirst
BANF
$3.77B
$77.1K ﹤0.01%
838
-7
-0.8% -$589
FOLD
1191
DELISTED
Amicus Therapeutics
FOLD
$77.1K ﹤0.01%
6,136
+50
+0.8% +$593
HEGD icon
1192
Swan Hedged Equity US Large Cap ETF
HEGD
$737M
$77K ﹤0.01%
4,161
+1,198
+40% +$21.4K
MGK icon
1193
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
$77K ﹤0.01%
1,635
EMXC icon
1194
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.9B
$76.9K ﹤0.01%
1,478
-1,026
-41% -$52K
BIV icon
1195
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$76.7K ﹤0.01%
1,019
+311
+44% +$23.7K
ARE icon
1196
Alexandria Real Estate Equities
ARE
$8.3B
$76.6K ﹤0.01%
675
+137
+25% +$16.3K
KYN icon
1197
Kayne Anderson Energy Infrastructure Fund
KYN
$2.45B
$76.5K ﹤0.01%
9,400
IXJ icon
1198
iShares Global Healthcare ETF
IXJ
$4.23B
$76.5K ﹤0.01%
900
JBGS
1199
JBG SMITH
JBGS
$648M
$76.1K ﹤0.01%
5,057
+2,788
+123% +$40.6K
MMS icon
1200
Maximus
MMS
$2.95B
$75.4K ﹤0.01%
892
-26
-3% -$2.14K

Similar funds

Parallel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Parallel Advisors held 3,618 positions worth $3.11B, up 4.7% from $2.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parallel Advisors's Q2 2023 filing shows 197 new, 1,211 increased, 1,200 reduced and 258 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $39.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K.
  • Parallel Advisors added most to iShares MSCI USA Quality Factor ETF in Q2 2023, an estimated $72.4M increase.
  • Parallel Advisors's biggest Q2 2023 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $39.5M.
  • Parallel Advisors fully exited Cvent Holding Corp. Common Stock in Q2 2023, selling an estimated $1.62M.
  • Parallel Advisors's ten largest holdings make up 32% of its $3.11B portfolio in Q2 2023.
  • Parallel Advisors opened 197 new positions and closed 258 in Q2 2023.
  • Parallel Advisors's portfolio value rose 4.7% quarter-over-quarter to $3.11B.

Based on Parallel Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.